We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | BIT:SANF | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/11/2024 | 06:00 | UKREG | Press Release: Dupixent sBLA accepted for FDA review for the treatment of.. |
| 15/11/2024 | 06:00 | UKREG | Communiqué de presse : La FDA a accepté l’examen de la sBLA pour le.. |
| 14/11/2024 | 16:42 | UKREG | Press Release: Sarclisa recommended for EU approval by the CHMP to treat.. |
| 14/11/2024 | 16:42 | UKREG | Communiqué de presse : Sarclisa : approbation recommandée par le CHMP dans.. |
| 06/11/2024 | 06:00 | UKREG | Communiqué de presse : Dupixent, premier et seul médicament approuvé dans.. |
| 06/11/2024 | 06:00 | UKREG | Press Release: Dupixent approved in the EU as the first and only medicine.. |
| 25/10/2024 | 05:30 | UKREG | Press Release: Sanofi Q3: 15.7% sales growth boosted by.. |
| 25/10/2024 | 05:30 | UKREG | Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue.. |
| 24/10/2024 | 12:00 | UKREG | Communiqué de presse : Dupixent : Présentation de nouvelles données.. |
| 24/10/2024 | 12:00 | UKREG | Press Release: Dupixent late-breaking positive phase 3 data in chronic.. |
Sanofi (SANF) Share Charts1 Year Sanofi Chart |
|
1 Month Sanofi Chart |
Intraday Sanofi Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
